Published in N Engl J Med on November 18, 2010
Kidney and Liver Transplantation in People With HIV | NCT00074386
Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide After Renal Transplant | NCT04530630
HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years. N Engl J Med (2015) 4.81
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc (2014) 1.41
Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country. PLoS One (2016) 1.39
The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol (2013) 1.34
Renal disease in HIV-infected individuals. Curr Opin HIV AIDS (2011) 1.15
A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients. J Am Soc Nephrol (2015) 1.12
Nephrotoxicity of HAART. AIDS Res Treat (2011) 1.10
Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant (2011) 1.07
Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients. Kidney Int (2015) 1.04
Tackling the unknowns in HIV-related kidney diseases. N Engl J Med (2010) 1.02
Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol (2012) 0.98
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. Am J Transplant (2014) 0.90
Kidney infection with HIV-1 following kidney transplantation. J Am Soc Nephrol (2013) 0.87
Renal transplantation between HIV-positive donors and recipients justified. S Afr Med J (2012) 0.87
Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients. Am J Transplant (2016) 0.87
Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. Transplantation (2014) 0.87
Infection of the fracture hematoma from skeletal traction in an asymptomatic HIV-positive patient. Acta Orthop (2012) 0.86
Treatment of postoperative infectious complications in patients with human immunodeficiency virus infection. World J Emerg Med (2014) 0.86
Update on current management of chronic kidney disease in patients with HIV infection. Int J Nephrol Renovasc Dis (2016) 0.85
Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient. Infect Dis Clin North Am (2013) 0.84
Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy. Crit Rev Immunol (2013) 0.83
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery (2012) 0.83
Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (2016) 0.82
Survival Benefit of Kidney Transplantation in HIV-infected Patients. Ann Surg (2016) 0.81
Antibody induction therapy in adult kidney transplantation: A controversy continues. World J Transplant (2012) 0.81
Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients. Transpl Immunol (2016) 0.81
Willingness to pursue live-donor kidney transplantation among waitlisted patients infected with human immunodeficiency virus (HIV): a preliminary investigation. Transplantation (2013) 0.80
Zygomycosis Associated with HIV Infection and Liver Transplantation. Patholog Res Int (2011) 0.80
Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharm Drug Dispos (2013) 0.80
Realizing HOPE: The Ethics of Organ Transplantation From HIV-Positive Donors. Ann Intern Med (2016) 0.79
Recurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantation. Am J Kidney Dis (2013) 0.79
Viral infection in renal transplant recipients. ScientificWorldJournal (2012) 0.79
Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World J Nephrol (2014) 0.79
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2011) 0.79
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2011) 0.79
Malignancy in the HIV-infected patients undergoing liver and kidney transplantation. Curr Opin Oncol (2012) 0.78
Access to Kidney Transplantation among HIV-Infected Waitlist Candidates. Clin J Am Soc Nephrol (2017) 0.78
Allowing HIV-positive organ donation: ethical, legal and operational considerations. Am J Transplant (2013) 0.78
Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy. PLoS One (2015) 0.77
HIV-positive-to-HIV-positive kidney transplantation. N Engl J Med (2015) 0.77
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation (2013) 0.76
Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol (2014) 0.76
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol (2014) 0.76
Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators. JAMA Surg (2015) 0.76
Impact of antiretroviral therapy on clinical outcomes in HIV (+) kidney transplant recipients: Review of 58 cases. F1000Res (2016) 0.75
Kidney transplantation in HIV-infected patients. Am J Kidney Dis (2011) 0.75
Kidney Transplantation in HIV-Infected Recipients: Encouraging Outcomes, but Registry Data Are No Longer Enough. J Am Soc Nephrol (2015) 0.75
Successful Orthotopic Heart Transplantation and Immunosuppressive Management in 2 Human Immunodeficiency Virus-Seropositive Patients. Tex Heart Inst J (2016) 0.75
Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals. Clin J Am Soc Nephrol (2017) 0.75
Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients. Am J Transplant (2016) 0.75
Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients. Am J Transplant (2016) 0.75
Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. Am J Transplant (2016) 0.75
Update on kidney transplantation in human immunodeficiency virus infected recipients. World J Nephrol (2016) 0.75
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions. Open Forum Infect Dis (2016) 0.75
Drug interactions and antiretroviral drug monitoring. Curr HIV/AIDS Rep (2014) 0.75
Decade in review-renal transplantation: A spectrum of advances in renal transplantation. Nat Rev Nephrol (2015) 0.75
First Canadian Case Report of Kidney Transplantation From an HIV-Positive Donor to an HIV-Positive Recipient. Can J Kidney Health Dis (2017) 0.75
Transplantation: HIV infection is no barrier to kidney transplantation. Nat Rev Nephrol (2011) 0.75
Hepatitis C virus infection and kidney transplantation: newer options and a brighter future ahead? Kidney Int (2015) 0.75
Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis. Clin Case Rep (2013) 0.75
Successful renal transplant in a pediatric patient with HIV-associated nephropathy. Indian J Urol (2017) 0.75
Renal transplantation in human immunodeficiency virus (HIV)-positive children. Pediatr Nephrol (2014) 0.75
Anti-proliferative therapy for HIV cure: a compound interest approach. Sci Rep (2017) 0.75
Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83
Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest (2003) 4.14
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.97
Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev (2006) 2.79
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology (2003) 2.76
Lymphocyte homeostasis. Semin Immunol (1997) 2.15
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep (1999) 2.15
Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol (1989) 2.13
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl (2006) 1.86
Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol (1986) 1.84
Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.80
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant (2007) 1.69
Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant (2009) 1.65
Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol (2000) 1.64
Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis (2007) 1.62
Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol (2003) 1.61
Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J Immunol (2002) 1.55
Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol (2001) 1.49
Recent progress in HIV-associated nephropathy. J Am Soc Nephrol (2002) 1.48
Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med (1992) 1.38
HIV-associated nephropathy: an urban epidemic. Semin Nephrol (2001) 1.15
Is the prevalence of HIV-associated nephropathy decreasing? Am J Nephrol (1999) 1.11
Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation (2005) 1.10
Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs (2008) 1.06
HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study. BMC Nephrol (2003) 1.05
Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses (1992) 1.00
Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses (2008) 0.98
Pharmacokinetic interactions between cyclosporine and protease inhibitors in HIV+ subjects. Drug Metab Pharmacokinet (2003) 0.97
Malignancy after kidney transplantation: still a challenge. Kidney Int (2007) 0.92
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol (2003) 11.94
Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol (2004) 4.51
Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest (2009) 4.51
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther (2005) 3.84
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS (2004) 3.46
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res (2007) 3.45
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. PLoS Med (2010) 3.24
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2005) 2.83
Urban land teleconnections and sustainability. Proc Natl Acad Sci U S A (2012) 2.66
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. J Clin Oncol (2009) 2.63
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 2.48
Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med (2013) 2.29
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med (2012) 2.14
Attendance at cardiac rehabilitation is associated with lower all-cause mortality after 14 years of follow-up. Heart (2012) 2.05
Rhodococcus equi infection. Lancet Infect Dis (2010) 2.00
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine (2008) 1.89
Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One (2012) 1.84
Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant (2007) 1.81
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PLoS One (2010) 1.77
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiol Behav (2006) 1.71
Raccoon rabies virus variant transmission through solid organ transplantation. JAMA (2013) 1.71
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med (2010) 1.67
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut (2010) 1.67
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial. Cephalalgia (2010) 1.67
Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol (2007) 1.64
Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant (2003) 1.64
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment. J Infect Dis (2012) 1.62
Racial and center differences in hemodialysis adequacy in children treated at pediatric centers: a North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report. J Am Soc Nephrol (2004) 1.62
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J (2006) 1.59
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl (2006) 1.59
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58
Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57
Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA (2003) 1.54
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation (2003) 1.54
Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation (2009) 1.54
Devastating and fatal complications associated with combined vascular and bile duct injuries during cholecystectomy. Arch Surg (2002) 1.54
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol (2009) 1.52
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation (2008) 1.52
Impact of comorbidities on hospitalization costs following hip fracture. J Bone Joint Surg Am (2012) 1.52
Radiographic imaging for patients with contagious infectious diseases: how to acquire chest radiographs of patients infected with the Ebola virus. AJR Am J Roentgenol (2015) 1.48
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am (2010) 1.47
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation (2003) 1.47
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. AIDS Res Hum Retroviruses (2007) 1.46
Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46
Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection. AIDS (2016) 1.45
Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med (2002) 1.45
Long-term behavioral outcomes after attendance at a secondary prevention clinic for cardiac patients. J Cardiopulm Rehabil (2003) 1.45
Ebola hemorrhagic fever in 2014: the tale of an evolving epidemic. Ann Intern Med (2014) 1.44
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol (2012) 1.44
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
Proposed live donor nephrectomy complication classification scheme. Transplantation (2006) 1.41
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.39
A pilot programme of organ donation after cardiac death in China. Lancet (2011) 1.39
A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. Pediatr Transplant (2005) 1.38
Omega jejunoduodenal anastomosis for pancreas transplant. J Am Coll Surg (2006) 1.37
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers. AIDS Res Hum Retroviruses (2009) 1.35
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34
Isolated levocardia: prenatal diagnosis, clinical importance, and literature review. J Ultrasound Med (2007) 1.34
Promotion of altruistic donation. Transplantation (2009) 1.33
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (2006) 1.32
Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation (2005) 1.32
Medical risks in living kidney donors: absence of proof is not proof of absence. Clin J Am Soc Nephrol (2006) 1.31
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol (2007) 1.29
Immunosuppression: practice and trends. Am J Transplant (2004) 1.28
The pathobiology of polyomavirus infection in man. Adv Exp Med Biol (2006) 1.27
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248. J Infect Dis (2013) 1.26
Norovirus infectivity in humans and persistence in water. Appl Environ Microbiol (2011) 1.26